TGA grant provisional registration to Moderna for booster dose

On December 7, 2021, TGA grant provisional approval for Moderna’s booster dose of their COVID-19 vaccine for 18 years and over.  This is the second COVID-19 vaccine to be used as a booster in Australian adults when they become eligible, six months after receiving their second dose the initial or primary vaccination course. [1, 2, 3]

“TGA provisionally approved the booster dose following careful evaluation of the available data supporting safety and efficacy. The TGA’s decision was also informed by expert advice from the Advisory Committee on Vaccines (ACV), an independent committee with scientific, clinical and consumer representation.”

The Australian Technical Advisory Group on Immunisation (ATAGI) must provide final approval for use, which occurred on December 12, 2021.